Published on:
Updated on:

If we're dealing with IM injections then we start in the 21g draw & 25g 1" injection needle range. This is typically the sweet spot for being able to get to the muscle even in overweight patients and ... See Full Answer
We tailor each plan individually, which includes supplies for injection. For that reason, there is no right or wrong choice for needle size. If a man has low body fat, or prefers the deltoids and vast... See Full Answer
Great question, and the answer is: It depends. IM has the benefit of being less frequent as you can inject larger volumes into muscle than you can into fat. If this makes a patient more compliant with... See Full Answer
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
Most people who dread their injection days are not dealing with an unavoidable reality - they are dealing with a technique problem that has a straightforward solution. The shallow intramuscular injection method, commonly associated with a 1-inch needle, has quietly become one of the most talked-about refinements in self-injection practice for people on testosterone replacement therapy and similar hormone protocols.
Intramuscular injection, at its core, means depositing medication into muscle tissue rather than into a vein or just beneath the skin. The term "shallow IM" refers to entering the muscle at a shallower depth than traditional deep intramuscular technique - reaching the upper portion of the muscle belly without driving a needle all the way through it toward deeper structures.
The distinction matters because muscle tissue is not a uniform block. The outer layer of a muscle sits relatively close to the surface, and for many adults, a 1-inch needle is sufficient to clear the skin and subcutaneous fat and land squarely in that muscle tissue - without overshooting into periosteum (the fibrous covering of bone), joint capsule territory, or deeply embedded nerve and vascular structures. That shorter journey is often the entire reason post-injection soreness improves.
Understanding post-injection discomfort starts with understanding what you are actually doing to tissue when you inject. Every needle insertion creates a small wound. The body responds with a local inflammatory process - a normal and expected healing response. Most mild soreness that peaks around 24 to 48 hours after an injection is simply that: tissue repair in progress.
But not all post-injection pain is created equal. Several factors tend to amplify discomfort beyond that baseline level:
Tissue trauma from depth. A needle that travels deeper than necessary passes through more tissue layers, creating a longer wound track and more disruption overall. Hitting the muscle's deep fascia, or pressing against the periosteum of an underlying bone, produces a distinctly sharp, aching pain that lingers.
Muscle tension during injection. Injecting into a tense, contracted muscle dramatically increases discomfort. The medication is essentially being forced into tissue that has no room to accept it comfortably.
Injection speed. Pushing medication in quickly creates pressure inside the muscle that the tissue has not had time to accommodate. That pressure translates directly into pain during the injection and inflammatory soreness afterward.
Volume and viscosity. Thicker oil-based medications and larger volumes require more time and a more relaxed muscle to distribute without creating a painful depot of fluid under pressure. This is a general principle - not every medication behaves the same way.
Hitting a nerve or blood vessel. Though statistically uncommon with proper technique, small nerve branches and capillaries run through every muscle. A needle that travels further has more opportunity to contact one.
Shallow IM addresses several of these factors at once. By staying in the upper muscle belly, the technique limits wound track length, reduces the risk of hitting deeper structures, and places the medication in a zone of tissue that tends to be well-vascularized and receptive to absorption.
These three approaches are genuinely different, and each has a context where it makes the most sense.
Traditional deep IM was developed largely for clinical settings, vaccine administration, and medications where rapid, predictable uptake into deep muscle was the priority. It uses longer needles and targets the full depth of large muscle groups. For someone administering a one-time vaccine in a clinical office, this approach is appropriate. For someone self-injecting an oil-based medication multiple times per week, injecting to maximum depth every time may create cumulative trauma and unnecessary soreness.
Subcutaneous injection deposits medication into the fat layer beneath the skin, above the muscle entirely. This approach is common for insulin, certain peptides, and some hormone protocols. The comfort profile for subcutaneous injections is often excellent because adipose tissue is less densely innervated than muscle. However, absorption characteristics differ from intramuscular injection, and not all medications are formulated or approved for subcutaneous use. Some individuals also find that subcutaneous depots of oil-based testosterone can cause local nodules or inconsistent absorption.
Shallow IM occupies a practical middle ground. It delivers medication into muscle tissue - preserving the absorption profile of an intramuscular injection - while reducing the depth of needle travel. For oil-based testosterone esters administered on a regular schedule, many people find this approach offers a meaningful improvement in comfort without compromising how the medication performs. That said, individual anatomy, body composition, and medication type all influence what technique actually works best in practice.
Not every muscle is equally well-suited for self-injection. The three most commonly used sites each have their own characteristics worth understanding.
The vastus lateralis, the outer thigh muscle, is a consistent favorite for self-injection because it is large, accessible, and easy to visualize and reach. It has relatively few major nerve and vascular structures in the typical injection zone and provides a substantial target. For shallow IM technique, the outer thigh tends to be forgiving and reliable.
The ventrogluteal site, on the side and rear of the hip, is widely regarded by injection technique specialists as one of the safest and most comfortable locations for IM injection. It offers significant muscle mass with minimal overlying fat variation and is well away from the sciatic nerve. Many people who switch from the dorsogluteal (upper buttock) site to ventrogluteal report an immediate improvement in comfort.
The deltoid, the shoulder muscle, is a common site for smaller injection volumes. It is accessible for self-injection and tends to produce minimal soreness when technique is clean. Volume limitations apply here - the deltoid is a smaller muscle and does not accommodate larger volumes as comfortably as the thigh or hip.
Rotating between sites is not optional for anyone injecting on a regular schedule. Repeated injection into the same small area creates scar tissue over time. Scar tissue absorbs medication poorly, is more painful to inject into, and can eventually distort muscle architecture. A consistent rotation pattern protects healthy tissue and keeps each site in optimal condition.
Beyond site selection and needle length, several technique habits consistently separate comfortable injections from painful ones.
Relaxation is non-negotiable. Injecting into a relaxed muscle means the tissue can accept the medication with less resistance. For thigh injections, sitting with the leg loose and unsupported works well. For ventrogluteal injections, shifting your weight to the opposite foot softens the target muscle. Even a brief pause to consciously release tension before inserting the needle makes a measurable difference.
Insertion angle influences how the needle moves through tissue. A perpendicular entry - straight into the muscle - minimizes the wound track and reduces dragging against tissue layers. Angled insertions cover more distance through the skin and fat before reaching muscle, and they can create a tearing sensation on withdrawal.
Steady, controlled insertion beats hesitant, multiple-stage entry every time. A slow, tentative needle insertion that pauses and resumes partway through drags the needle tip across nerve endings in the skin. A single smooth motion is faster and less traumatic, even if it feels counterintuitive.
Slow injection speed is one of the highest-impact technique changes available. Allowing ten to thirty seconds for even a modest injection volume gives the muscle time to accommodate the incoming fluid. Rushing this step is one of the most common causes of the deep, aching post-injection soreness that people associate with testosterone injections specifically.
Post-injection care is genuinely underrated. Gentle pressure with a clean gauze pad for a brief moment after needle removal helps close the small wound. Light movement of the injected muscle afterward - a short walk, some easy leg movements - encourages distribution of the medication and reduces the likelihood of a concentrated, uncomfortable depot forming.
Clean technique protects against complications that have nothing to do with injection depth or needle length. Alcohol swabbing of the injection site before entry, handling needles and syringes without contaminating the needle shaft, and never reusing needles are baseline practices without exceptions.
Mild soreness at the injection site, sometimes with minor bruising, is normal. It should peak within a day or two and resolve on its own. A small amount of localized firmness beneath the skin is also common as the medication absorbs.
The following are not normal and warrant prompt contact with a clinician: increasing redness, warmth, or swelling at the site that worsens after 48 hours rather than improving; fever; purulent discharge; a hard, growing lump; or pain that is severe, spreading, or accompanied by systemic symptoms. Injection-site infections are uncommon with proper hygiene, but they do occur and respond well to early treatment. Waiting to see if a worsening site improves on its own is not a safe strategy.
It is worth stating directly: no single injection technique works identically for every person. Body composition, muscle density, subcutaneous fat distribution, and the specific medication being injected all influence which approach produces the best comfort and consistency. Someone with very lean thighs may find that a 1-inch needle at a perpendicular angle reaches deeper than intended. Someone with more subcutaneous tissue may find the same setup perfectly calibrated for shallow IM. These variables are real, and they are the reason technique review with a prescribing clinician matters.
A knowledgeable provider can assess your individual anatomy and the specific characteristics of your medication and offer guidance tailored to your situation. Generic technique advice - including everything in this article - is educational context, not a substitute for that individualized review.
Injection days do not have to be something people brace themselves for. The persistent myth that IM injections are inherently painful has kept many people tolerating unnecessary soreness when relatively simple technique refinements could meaningfully improve their experience. Shallow IM technique, using a 1-inch needle, combined with thoughtful site selection, a relaxed muscle, slow injection speed, and a consistent rotation schedule, removes most of the variables that cause real post-injection discomfort.
The approach is not a workaround or a shortcut - it is a technique grounded in the understanding that medication only needs to reach muscle tissue, not the deepest possible point within a muscle. When that principle guides technique choices, comfort improves without sacrificing effectiveness.
For anyone navigating TRT who wants structured guidance on injection technique, ongoing education, and clinical support from providers who take the practical side of hormone therapy seriously, AlphaMD offers telehealth-based TRT care that includes exactly that kind of coaching. Getting the technique right from the beginning, or refining it at any point, is a legitimate and worthwhile part of managing your protocol well.
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
If we're dealing with IM injections then we start in the 21g draw & 25g 1" injection needle range. This is typically the sweet spot for being able to get to the muscle even in overweight patients and ... See Full Answer
We tailor each plan individually, which includes supplies for injection. For that reason, there is no right or wrong choice for needle size. If a man has low body fat, or prefers the deltoids and vast... See Full Answer
Great question, and the answer is: It depends. IM has the benefit of being less frequent as you can inject larger volumes into muscle than you can into fat. If this makes a patient more compliant with... See Full Answer
Enter your email address now to receive $30 off your first month’s cost, other discounts, and additional information about TRT.
This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual. The content of this website is for informational purposes only. The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider. Only a qualified physician in your state can determine if you qualify for and should undertake treatment.